When does Rubicon Research IPO subscription close?

Rubicon Research IPO subscription closes on 2025-10-13.

RUBICONEQ / NSE, BSEListed

Rubicon Research

Rubicon Research Limited, incorporated in 1999, is a pharmaceutical company focused on developing, manufacturing, and commercializing differentiated formulations. As of June 30, 2025, it has 72 US FDA-approved ANDA and NDA products, with 66 commercialized in a US generic market worth USD 2,455.7 million, contributing USD 195 million in Fiscal 2024. The company has 17 products awaiting US FDA approval and 63 in development, marketing over 350 SKUs to 96 customers, including major wholesalers, pharmacy chains, GPOs, and managed care organizations. Globally, Rubicon has registered or filed 48 products across Australia, the UK, Singapore, Saudi Arabia, and the UAE, planning commercial launch upon approval, and offers contract manufacturing in India, Australia, and New Zealand. Its operations include three manufacturing facilities in India and two US FDA-inspected R&D centers in India and Canada.

drhp anchor

₹461 - ₹485109.33x sub

Listed Price₹620.10

Listing Gain+27.86%

RUBICONEQ / NSE, BSEListed

Rubicon Research IPO Subscription

Q: What is the live subscription status of Rubicon Research IPO?

Rubicon Research IPO has been subscribed 109.33x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Individual Investors.

drhp Document anchor Document

Price Band₹461 - ₹485

Lot Size30 shares

Min Bid₹14,550

Subscription109.33x

Listed Market Snapshot

₹620.10Listed price from market data

+27.86%listing gain

Issue Amount

₹1,377.5 Cr

Listed Price

₹620.10

Current Price

₹1486.7

Registrar

Link Intime India Private Ltd (MUFG)

Subscription Status

109.33xTotal Demand

Updated 20 Oct 2026, 01:30 AM

QIB137.09x

🔥 Blockbuster Sizzling Demand!Offered: 85,06,804 sh

Nib102.71x

🔥 Blockbuster Sizzling Demand!Offered: 42,54,299 sh

Hnis(10l +)117.77x

🔥 Blockbuster Sizzling Demand!Offered: 28,36,200 sh

Hnis (2-10l)72.57x

🔥 Blockbuster Sizzling Demand!Offered: 14,18,100 sh

Retail37.33x

🔥 Blockbuster Sizzling Demand!Offered: 28,36,200 sh

Employees17.69x

Hot Bidding (High Profits)Offered: 40,046 sh

Category	Offered (Shares)	Applied (Shares)	Times Subscribed
QIB	85,06,804	1,16,61,67,740	137.09x
Nib	42,54,299	43,69,39,170	102.71x
Hnis(10l +)	28,36,200	33,40,22,190	117.77x
Hnis (2-10l)	14,18,100	10,29,16,980	72.57x
Retail	28,36,200	10,58,65,470	37.33x
Employees	40,046	7,08,240	17.69x

Category	Offered	Applied	Times
QIB	85,06,804	1,16,61,67,740	137.09x
Nib	42,54,299	43,69,39,170	102.71x
Hnis(10l +)	28,36,200	33,40,22,190	117.77x
Hnis (2-10l)	14,18,100	10,29,16,980	72.57x
Retail	28,36,200	10,58,65,470	37.33x
Employees	40,046	7,08,240	17.69x

Segment Subscription Demand

Segment / Category	Demand (Shares)	Offered (Shares)	Times Sub.
QIB	56,559.14	412.58	137.09x
Fiis	16,406.1	0	Open
Fis	24,566.34	0	Open
Mutual Funds	2,842.57	0	Open
Others	12,744.13	0	Open
Retail	5,134.48	137.56	37.33x
Hnis 2+	4,991.47	68.78	72.57x
Hnis 10+	16,200.08	137.56	117.77x
Employees	34.35	1.94	17.71x

Application-wise Breakup

Category	Reserved	Applied	Times Sub.
Retail	94,540	27,93,192	29.55x
Employees	0	15,968	Open
Hnis(10l +)	6,753	1,55,448	23.02x
Hnis (2-10l)	3,376	2,34,124	69.35x

Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Rubicon Research IPO Subscription Demand

Live subscription status and bidding analysis for Rubicon Research (RUBICON) IPO. The issue is subscribed 109.33x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.